Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Ketone ester
COGNITION THERAPEUTICS INC
Hypoxia
2 trials -
L-Carnitine tartrate
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial -
LCAR-M61S cells preparation
Nanjing Legend Biotech Co.
Relapsed/Refractory Multiple Myeloma
1 trial -
LCI+white light
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Early Gastric Cancer
1 trial -
LOC387715/HTRA1 genotyping
Hospital Authority, Hong Kong
Age-Related Macular Degeneration
1 trial -
Lactated ringers solution
The First People's Hospital of Lianyungang
Pancreatitis, Chronic
1 trial -
Lactobacillus rhamnosus F-1
Biotech Pharmaceutical Co.,
Allergic Rhinitis
1 trial -
Lactose-free milk formula (Frisolac LF ®)
Hospital Authority, Hong Kong
Acute Gastroenteritis
1 trial -
Latanoprost
The First People's Hospital of Lianyungang
Ocular Hypertension
1 trial -
Learning with 3D-MR visualization models
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Teaching Innovation
1 trial -
Leflunomide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ANCA Associated Vasculitis
1 trial -
Letrozole
The First People's Hospital of Lianyungang
Intrauterine Insemination
1 trial -
Letrozole
International Peace Maternity and Child Health Hospital
Letrozole
1 trial -
Leuprorelin acetate + Sintilimab
The First People's Hospital of Lianyungang
NSCLC, Stage III
1 trial -
Levetiracetam (Keppra)
United Therapeutics Europe Ltd
Alcohol Abuse
1 trial -
Levofloxacin
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
3 trials -
Linaclotide
Second Affiliated Hospital of Xi'an Jiaotong University
Bowel Preparation
1 trial -
Lipid-based nutrient supplement
United Therapeutics Europe Ltd
Malnutrition
1 trial -
Liposomal Doxorubicin
United Therapeutics Europe Ltd
Ovarian Cancer
1 trial -
LiveSpo Navax
Hospital Authority, Hong Kong
Acute Respiratory Tract Infections
1 trial -
Local Anesthetics,Topical
United Therapeutics Europe Ltd
Pain
1 trial -
Low dose Radiotherapy
United Therapeutics Europe Ltd
Covid19
1 trial -
Low potassium content vegetables
Xiyuan Hospital of China Academy of Chinese Medical Sciences
End-stage Renal Disease
1 trial -
Low strength nicotine e-liquid
BRIGHT MINDS BIOSCIENCES INC.
Electronic Cigarette Use
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources